Patent · US Active

Compounds for the treatment of inflammatory disorders

US8541572B2 · kind B2 · utility

2Cited by

15References

4Claims

0Family size

Assignee

Merck Sharp & Dohme LLC · US

Inventors

Joseph A. Kozlowski · Princeton, US
Wensheng Yu · Edison, US
Michael K. C. Wong · New Brunswick, US
Seong Heon Kim · Livingston, US
Ling Tong · Hackettstown, US
Brian J. Lavey · New Providence, US
Bandarpalle B. Shankar · Readington, US
De-Yi Yang · Morristown, US
Robert Feltz · Parsippany, US
Aneta Maria Kosinski · South Amboy, US
Guowei Zhou · Somerville, US
Razia Rizvi · Bloomfield, US
Chaoyang Dai · Acton, US
Luke Fire · Cambridge, US
Vinay M. Girijavallabhan · Woburn, US
Dansu Li · New York, US
Janeta Popovici-Muller · Windham, US
Judson E. Richard · Kittery, US
Kristin E. Rosner · Watertown, US
M. Arshad Siddiqui · Newton, US
Liping Yang · Arlington, US

Key dates

Filing date	Nov 9, 2009
Grant date	Sep 24, 2013
Priority date	—
Expiry date	Nov 17, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to compounds of the Formula (I): (Chemical formula should be inserted here as it appears on abstract in paper form) (I) or a pharmaceutically acceptable salt, solvate or isomer thereof, which can be useful for the treatment of diseases or conditions mediated by MMPs, ADAMs, TACE, aggrecanase, TNF—or combinations thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.